National assessment of frailty impact on endovascular mechanical thrombectomy for minor to moderately severe large vessel occlusions per NIHSS

根据美国国立卫生研究院卒中量表(NIHSS)评估衰弱对轻度至中度严重大血管闭塞患者行血管内机械取栓术的影响。

阅读:1

Abstract

IntroductionLarge vessel occlusion (LVO) strokes are a significant cause of disability and death globally. Endovascular mechanical thrombectomy (EVT) has improved outcomes for LVO patients. However, the impact of pre-existing frailty on outcomes for patients undergoing EVT remains understudied.MethodsThis study utilized the National Inpatient Sample (NIS) database to identify patients aged 18 and older who underwent EVT for LVO of the internal carotid artery (ICA) or middle cerebral artery (MCA) from 2016 to 2021. Frailty was assessed using the modified Frailty Index-5 (mFI-5), mFI-11, Charlson Comorbidity Index (CCI), and Risk Analysis Index (RAI). Outcomes analyzed included mortality, complications, length of stay (LOS), discharge disposition, and cost of care.ResultsWe analyzed 57,260 EVT admissions. Patients classified as highly frail by the CCI had the highest in-hospital mortality (odds ratio (OR) 1.13, p < 0.0001). High frailty identified by mFI-5 was associated with a higher likelihood of postoperative complications (OR 1.41, p < 0.0001) and extended LOS (OR 1.23, p < 0.0001). High frailty by the administrative RAI was linked to nonhome discharge (OR 1.31, p < 0.0001), with mFI-5 showing similar predictive value (OR 1.30, p < 0.0001). High frailty, as determined by the CCI, incurred the highest estimated cost of care (p < 0.0001).ConclusionsFrailty assessment using mFI-5 is a practical predictor of patient outcomes in LVO thrombectomy, including complication rates, extended LOS, and discharge disposition. The CCI remains the most predictive for mortality, though it is more complex to calculate. We emphasize that frailty, as measured by the mFI-5, is one of many factors to consider when deciding on EVT for LVO.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。